RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arcus Biosciences - Stock

Arcus Biosciences P/S 2024

Arcus Biosciences P/S

5.47

Ticker

RCUS

ISIN

US03969F1093

WKN

A2JGDZ

As of Jun 19, 2024, Arcus Biosciences's P/S ratio stood at 5.47, a -57.4% change from the 12.84 P/S ratio recorded in the previous year.

The Arcus Biosciences P/S history

Arcus Biosciences Aktienanalyse

What does Arcus Biosciences do?

Arcus Biosciences Inc is a biotechnology company based in Hayward, California, which focuses on developing novel therapeutics for the treatment of cancer and other serious diseases. The company was founded in 2016 and went public in 2018. Arcus Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Arcus Biosciences's P/S Ratio

Arcus Biosciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Arcus Biosciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Arcus Biosciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Arcus Biosciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Arcus Biosciences Stock

What is the price-to-earnings ratio of Arcus Biosciences?

The price-earnings ratio of Arcus Biosciences is currently 5.47.

How has the price-earnings ratio of Arcus Biosciences changed compared to last year?

The price-to-earnings ratio of Arcus Biosciences has increased by -57.4% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Arcus Biosciences high compared to other companies?

Yes, the price-to-earnings ratio of Arcus Biosciences is high compared to other companies.

How does an increase in the price-earnings ratio of Arcus Biosciences affect the company?

An increase in the price-earnings ratio of Arcus Biosciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Arcus Biosciences affect the company?

A decrease in the price-earnings ratio of Arcus Biosciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Arcus Biosciences?

Some factors that influence the price-earnings ratio of Arcus Biosciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Arcus Biosciences pay?

Over the past 12 months, Arcus Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcus Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcus Biosciences?

The current dividend yield of Arcus Biosciences is .

When does Arcus Biosciences pay dividends?

Arcus Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcus Biosciences?

Arcus Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcus Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcus Biosciences located?

Arcus Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arcus Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcus Biosciences from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Arcus Biosciences pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of Arcus Biosciences in the year 2023?

In the year 2023, Arcus Biosciences distributed 0 USD as dividends.

In which currency does Arcus Biosciences pay out the dividend?

The dividends of Arcus Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arcus Biosciences

Our stock analysis for Arcus Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arcus Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.